• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: RAYNER INTRAOCULAR LENSES LIMITED SULCOFLEX

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

RAYNER INTRAOCULAR LENSES LIMITED SULCOFLEX Back to Search Results
Model Number NOT AVAILABLE
Device Problem Material Opacification (1426)
Patient Problem Visual Impairment (2138)
Event Type  malfunction  
Manufacturer Narrative
The reference (b)(4) has been allocated to this case by rayner.The event description provided states that post-operatively the patient has presented with opacification of the supplementary sulcoflex iol.No further event information is available to rayner at this time.Additional information has been requested from the reporter to facilitate further investigation of the event."precipitates" is listed in the "adverse events" section of the ifu.Primary calcification is inherent.It is due to particular manufacturing processes or packaging interactions.An examination of the literature shows that some manufacturers have had known cases of primary calcification due to an interaction with silicone in the packaging - and more recently, due to phosphate remnants (originating from a detergent) found in the manufacturing process.Rayner has made no material processing or packaging changes that may have negatively affected our iols; we have never had a confirmed case of primary calcification relating to a rayner iol.Secondary calcification affects many manufacturers and is a phenomenon that is not fully understood; it is known that it stems from changes in the eye's environment due to patient comorbidity, secondary surgeries and potentially other, poorly understood interactions: off label use of intracameral alteplase (actilyse) (rtpa), multifactorial, high phosphate content ophthalmic viscoelastic devices , repeated exposure to intracameral air, raised intraocular pressure, excessive post-operative inflammation, complicated, traumatised eyes, as a result of direct contact between the iol surface and the exogenous gas or substance, a metabolic change in the anterior chamber due to the presence of exogenous gas/substance in the eye or an exacerbated inflammatory reaction after multiple surgical procedures, trauma or repeat surgery involved in re-bubbling potentially disrupting the blood aqueous barrier, increasing concentration of calcium ions.There is insufficient evidence and information available to establish the root cause of the onset of post-operative iol opacification in this case.
 
Event Description
On (b)(6) 2023, rayner received notification from a uk healthcare facility of an event that occurred following implantation of a supplementary sulcoflex iol (model unspecified).The event description provided states that post-operatively, the patient has presented with opacification of the iol.Note: supplementary sulcoflex iols are not available in the usa; however, as they're manufactured from the same hydrophilic acrylic material as rayner models licensed for sale in the usa, the event is being reported to fda.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SULCOFLEX
Type of Device
SULCOFLEX
Manufacturer (Section D)
RAYNER INTRAOCULAR LENSES LIMITED
the ridley innovation centre
10 dominion way
worthing, west sussex BN14 8AQ
UK  BN14 8AQ
Manufacturer (Section G)
RAYNER INTRAOCULAR LENSES LIMITED
the ridley innovation centre
10 dominion way
worthing, west sussex BN14 8AQ
UK   BN14 8AQ
Manufacturer Contact
jodie neal
the ridley innovation centre
10 dominion way
worthing, west sussex BN14 -8AQ
UK   BN14 8AQ
MDR Report Key17910455
MDR Text Key325353243
Report Number3012304651-2023-00137
Device Sequence Number1
Product Code HQL
Combination Product (y/n)N
Reporter Country CodeUK
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 10/11/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/11/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberNOT AVAILABLE
Device Catalogue NumberNOT AVAILABLE
Device Lot NumberNOT AVAILABLE
Is the Reporter a Health Professional? Yes
Date Manufacturer Received10/05/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-